Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02507466 · ClinicalTrials.gov registry record · NA

Very Intensive Variable Repetitive AmbulatioN Training

A NA study of Stroke, sponsored by Shirley Ryan AbilityLab.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT02507466: Completed NA study of Stroke, sponsored by Shirley Ryan AbilityLab.

NCT02507466 is a NA study of Stroke that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 90 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02507466, a NA study of Stroke, has completed, sponsored by Shirley Ryan AbilityLab.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this subproject is to evaluate the individual and paired contributions of intensity and variability of stepping training on lower extremity (LE) function, health and community participation in patients with chronic hemiparesis post-stroke.

Conditions Studied

Interventions

  • BEHAVIORAL exercise

Study Locations (1)

Illinois

  • Rehabilitation Institute of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2015-07
Est. Completion 2019-10
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT02507466

The ClinicalTrials.gov registry entry for NCT02507466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which exercise is the first listed.

NCT02507466 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT02507466 about?

NCT02507466 is a clinical study titled "Very Intensive Variable Repetitive AmbulatioN Training". The overall objective of this subproject is to evaluate the individual and paired contributions of intensity and variability of stepping training on lower extremity (LE) function, health and community participation in patients with chronic hemiparesis post-stroke.

What is the current status of trial NCT02507466?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-07. Estimated completion is 2019-10.

What conditions does trial NCT02507466 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT02507466?

The interventions under investigation include: exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT02507466?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02507466 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.